Abstract
Esophageal cancer is a highly lethal malignancy and esophagectomy is a major operation with significant risk of morbidity and mortality. It is helpful to have tools to stratify for risk of resection to aid in surgical selection, counseling, and operative planning. The authors have chosen the presence or absence of sarcopenia as a potentially useful predictive tool in risk assessment for esophagectomy, as it has been found to be predictive of perioperative complications, mortality, and decreased survival for other solid tumors. Sarcopenia is not associated with morbidity, mortality, or recurrence after esophagectomy for cancerThe American Journal of SurgeryVol. 215Issue 5PreviewSarcopenia is associated with increased morbidity and mortality in hepatic, pancreatic and colorectal cancer. We examined the effect of sarcopenia on morbidity, mortality, and recurrence after resection for esophageal cancer. Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
